What is Zacks Research’s Estimate for Allstate Q2 Earnings?

The Allstate Co. (NYSE:ALL) – Zacks Research upped their Q2 2026 earnings estimates for Allstate in a note issued to investors on Wednesday, December 18th. Zacks Research analyst Z. Masood now forecasts that the insurance provider will earn $3.47 per share for the quarter, up from their prior estimate of $3.46. The consensus estimate for Allstate’s current full-year earnings is $16.26 per share.

Allstate (NYSE:ALL) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company had revenue of $16.63 billion for the quarter, compared to the consensus estimate of $14.57 billion. During the same period last year, the business posted $0.81 EPS. Allstate’s quarterly revenue was up 14.7% on a year-over-year basis.

A number of other analysts have also recently weighed in on the stock. Morgan Stanley raised their price target on shares of Allstate from $220.00 to $228.00 and gave the company an “overweight” rating in a report on Thursday, November 7th. Barclays raised their price objective on Allstate from $175.00 to $187.00 and gave the stock an “underweight” rating in a research note on Thursday, October 31st. The Goldman Sachs Group upped their price target on shares of Allstate from $209.00 to $230.00 and gave the company a “buy” rating in a report on Friday, November 15th. TD Cowen raised their price objective on shares of Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research note on Tuesday, September 3rd. Finally, Wells Fargo & Company lifted their price target on Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Allstate has an average rating of “Moderate Buy” and an average price target of $217.19.

Allstate Stock Performance

Shares of NYSE:ALL opened at $193.56 on Monday. Allstate has a 52 week low of $134.17 and a 52 week high of $209.88. The firm has a 50 day moving average of $195.72 and a 200 day moving average of $182.38. The company has a market capitalization of $51.26 billion, a price-to-earnings ratio of 12.54, a price-to-earnings-growth ratio of 1.70 and a beta of 0.50. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be issued a $0.92 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.90%. Allstate’s payout ratio is 23.83%.

Institutional Investors Weigh In On Allstate

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ALL. State Street Corp increased its holdings in Allstate by 1.1% in the third quarter. State Street Corp now owns 11,496,306 shares of the insurance provider’s stock valued at $2,190,758,000 after buying an additional 126,922 shares during the last quarter. Geode Capital Management LLC raised its position in Allstate by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider’s stock valued at $1,178,164,000 after purchasing an additional 74,537 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of Allstate by 18.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock worth $569,114,000 after buying an additional 472,040 shares during the last quarter. Raymond James & Associates grew its stake in shares of Allstate by 10.6% in the 3rd quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider’s stock valued at $287,851,000 after purchasing an additional 145,986 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Allstate by 3.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider’s stock valued at $229,545,000 after buying an additional 47,038 shares during the period. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.